Opinion

Video

Examining the 505(b)(2) Pathway and Implementation into EHR

A panelist discusses how the 505(b)(2) regulatory pathway provides a streamlined approval process for modified versions of previously approved drugs, allowing pharmaceutical companies to rely partly on existing safety/efficacy data while still requiring new clinical data, commonly used across various therapeutic areas including reformulations, new dosage forms, and drug combinations.

Video content above is prompted by the following:

  • Can you discuss the background and rationale of the 505(b)(2) pathway and in which fields of medicine it is used in?
  • As a pharmacist, in what ways are you working with the 505(b)(2) pathway in your everyday practice?
Related Videos
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
3 experts are featured in this series.
5 experts in this video
5 experts in this video
3 experts are featured in this series.
3 experts are featured in this series.